Dual-peptide engineered macrophage membrane biomimetic nanosystem via targeting Rg1 delivery for traumatic brain injury therapy
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 20.03.2026. Verfasst von Weiquan Liao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Traumatic brain injury (TBI) induces a detrimental inflammatory microenvironment at the lesion site, which, together with neuronal death and loss, leads to neurological dysfunction. The blood–brain barrier (BBB) further impedes intracerebral drug delivery, posing a major challenge for post-TBI therapy. To overcome this, we developed a brain-targeted biomimetic nanosystem (R/T-MaM-NPs) using an engineered dual-peptide-modified macrophage membrane (MaM). This system encapsulates neuroprotective ginsenoside Rg1 into poly (lactic-co-glycolic acid)-based nanoparticles (NPs). RAW264.7 macrophages were engineered to co-express targeting peptides (RVG and T7) on their membranes; the derived R/T-MaM was then coated onto NPs. The MaM coating conferred high biocompatibility and biosafety, enabling R/T-MaM-NPs to reduce immune clearance and prolong systemic circulation. By leveraging the intrinsic inflammatory chemotaxis of MaM and dual-peptide targeting, the integrated system promoted traversal across the BBB and subsequent accumulation around the cerebral lesion, thereby inducing the transdifferentiation of reactive astrocytes (RAs) into electrophysiologically functional neuron-like cells. RNA sequencing confirmed significant upregulation of neurogenic genes in R/T-MaM-NP-treated RAs, an outcome closely linked to suppression of the Wnt/Notch signaling pathway. Furthermore, R/T-MaM-NPs remodeled the inflammatory microenvironment at the TBI site, alleviated cerebral edema, and enhanced the recovery of cognitive and motor functions in TBI mice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu 226001, China.
- Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
- Jiangsu Medical Innovation Center, Neurological Disease Diagnosis and Treatment Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
ORCID-Profile: Youlang Zhou, Peipei Gong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liao, W., Lu, Z., Li, Z., Wang, C., Zhu, X., Zhu, J., Zhu, Y., Lin, J., Wen, J., Chen, X., Chen, J., Shen, J., Zhou, Y., & Gong, P. (2026). Dual-peptide engineered macrophage membrane biomimetic nanosystem via targeting Rg1 delivery for traumatic brain injury therapy. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag059
Vancouver
Liao W, Lu Z, Li Z, Wang C, Zhu X, Zhu J, et al. Dual-peptide engineered macrophage membrane biomimetic nanosystem via targeting Rg1 delivery for traumatic brain injury therapy. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag059
BibTeX
@article{Liao2026,
author = {Liao, Weiquan and Lu, Zhichao and Li, Ziheng and Wang, Chenxing and Zhu, Xingjia and Zhu, Jue and Zhu, Yongqi and Lin, Jialiang and Wen, Jiajia and Chen, Xuanfeng and Chen, Jian and Shen, Jianhong and Zhou, Youlang and Gong, Peipei},
title = {Dual-peptide engineered macrophage membrane biomimetic nanosystem via targeting Rg1 delivery for traumatic brain injury therapy},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag059}
}
EUVIMED